Unique variants in the CYP2J2 gene

Information The variants shown are described using the NM_000775.2 transcript reference sequence.

10 entries on 1 page. Showing entries 1 - 10.
Legend   How to query  

Effect     

Reported     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

Haplotype     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Owner     
+/+ 2 1 c.-76G>T r.(=) p.(=) CYP2J2*7 - NA, pathogenic g.60392494C>A g.59926822C>A -76G>T - CYP2J2_000009 Enzime activity in_vitro: Reduced transcription due to loss of Sp1 binding site, 1 more item Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee, 1 more item - - Germline, In vitro (cloned) - - - - - Julia Lopez
-?/-? 2 2 c.344C>T r.(=) p.(Pro115Leu) CYP2J2*10 - likely benign g.60381639G>A g.59915967G>A 10780C>T (P115L) - CYP2J2_000008 reference haplotype CYP2J2*10 Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee, PubMed: Gaedigk 2006 - - Germline - - - - - Julia Lopez
-?/-? 2 3 c.427A>G r.(=) p.(Thr143Ala) CYP2J2*2 - likely benign, NA g.60377930T>C g.59912258T>C 14489A>G (T143A) - CYP2J2_000007 Enzime activity in_vitro: Reduced AA and LA metabolism , reference haplotype CYP2J2*2 Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee, PubMed: King 2002 - rs55753213 Germline, In vitro (cloned) - - - - - Julia Lopez
-?/-? 2 3 c.472C>T r.(=) p.(Arg158Cys) CYP2J2*3 - likely benign, NA g.60377885G>A g.59912213G>A 14534C>T (R158C) - CYP2J2_000006 Enzime activity in_vitro: Reduced AA and LA metabolism , reference haplotype CYP2J2*3 Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee, PubMed: King 2002 - - Germline, In vitro (cloned) - - - - - Julia Lopez
?/. 1 - c.487G>C r.(?) p.(Ala163Pro) - - VUS g.60377870C>G - CYP2J2(NM_000775.2):c.487G>C (p.(Ala163Pro)) - CYP2J2_000010 VKGL data sharing initiative Nederland - - - CLASSIFICATION record - - - - - VKGL-NL_Leiden
-?/-? 2 4 c.575T>A r.(=) p.(Ile192Asn) CYP2J2*4 - likely benign, NA g.60377389A>T g.59911717A>T 15030T>A (I192N) - CYP2J2_000005 Enzime activity in_vitro: Reduced AA metabolism , reference haplotype CYP2J2*4 Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee, PubMed: King 2002 - rs66515830 Germline, In vitro (cloned) - - - - - Julia Lopez
-?/-? 2 6 c.934G>A r.(=) p.(Gly312Arg) CYP2J2*8 - likely benign g.60373527C>T g.59907855C>T 18892G>A (G312R) - CYP2J2_000004 reference haplotype CYP2J2*8 Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee, PubMed: Lee 2005 - rs150461093 Germline - - - - - Julia Lopez
-?/-? 2 6 c.1024G>A r.(=) p.(Asp342Asn) CYP2J2*5 - likely benign, NA g.60370710C>T g.59905038C>T 21709G>A (D342N) - CYP2J2_000003 Enzime activity in_vitro: Normal metabolism of AA and LA , reference haplotype CYP2J2*5 Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee, PubMed: King 2002 - rs56053398 Germline, In vitro (cloned) - - - - - Julia Lopez
-?/-? 2 7 c.1052C>T r.(=) p.(Pro351Leu) CYP2J2*9 - likely benign g.60370682G>A g.59905010G>A 21737C>T (P351L) - CYP2J2_000002 reference haplotype CYP2J2*9 Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee, PubMed: Lee 2005 - rs148429756 Germline - - - - - Julia Lopez
-?/-? 2 8 c.1210A>T r.(=) p.(Asn404Tyr) CYP2J2*6 - likely benign, NA g.60366757T>A g.59901085T>A 25662A>T (N404Y) - CYP2J2_000001 Enzime activity in_vitro: Reduced AA and LA metabolism, reference haplotype CYP2J2*6 Reference haplotype - Human P450 (CYP) Allele Nomenclature Committee, PubMed: King 2002 - rs72547598 Germline, In vitro (cloned) - - - - - Julia Lopez
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.